Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-253472

President & CEO sold 5,466 shares at an average $19.44 ($106,253)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Warmuth Markus · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Sale : show line 1 in the form 10b5-1 −4,998 $19.41 $97,021 595,006 D
2026-06-01 Sale : show line 2 in the form 10b5-1 −468 $19.73 $9,232 594,538 D
Open-market sales · 5,466 sh · avg $19.44 · $106,253
Loading xslF345X06/ownership.xml…